Sylvain Godreuil Selected Research

Biomarkers (Surrogate Marker)

2/2023	Evaluation of the impact of COVID-19 in people coinfected with HIV and/or tuberculosis in low-income countries: study protocol for mixed methods research in Burkina Faso.
1/2017	Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvain Godreuil Research Topics

Disease

10	Infections 10/2023 - 04/2009
6	Tuberculosis (Tuberculoses) 01/2022 - 05/2013
3	Neoplasms (Cancer) 01/2019 - 01/2017
2	COVID-19 02/2023 - 01/2023
1	Rabies (Hydrophobia) 11/2023
1	Lung Diseases (Lung Disease) 10/2022
1	Pleuropneumonia 09/2022
1	Fever (Fevers) 09/2022
1	Aseptic Meningitis 01/2022
1	Pneumonia (Pneumonitis) 01/2021
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2021
1	Infertility (Sterility) 01/2020
1	Cystic Fibrosis (Mucoviscidosis) 03/2018
1	Latent Tuberculosis 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Bacteremia 01/2014
1	Sacroiliitis 01/2014
1	Pulmonary Tuberculosis 03/2012
1	Superinfection 03/2012
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2012
1	Infection with Mycobacterium marinum 11/2011
1	Burns 06/2011

Drug/Important Bio-Agent (IBA)

4	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 01/2014
2	carbapenemaseIBA 11/2023 - 12/2018
2	Biomarkers (Surrogate Marker)IBA 02/2023 - 01/2017
2	AntibodiesIBA 02/2023 - 01/2018
2	SuspensionsIBA 10/2022 - 01/2020
2	Amikacin (A.M.K)FDA LinkGeneric 10/2022 - 03/2018
2	GoldIBA 01/2022 - 01/2019
2	CytokinesIBA 01/2022 - 01/2016
1	beta-Lactamases (beta-Lactamase)IBA 11/2023
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 10/2023
1	Reverse Transcriptase InhibitorsIBA 01/2023
1	NucleosidesIBA 01/2023
1	Integrase InhibitorsIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Liposomes (Liposome)IBA 10/2022
1	C-Reactive ProteinIBA 09/2022
1	SteroidsIBA 01/2022
1	Polysaccharides (Glycans)IBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	MacrolidesIBA 01/2021
1	Sucrose (Saccharose)IBA 12/2020
1	AgarIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	EnzymesIBA 01/2018
1	Nucleic AcidsIBA 01/2018
1	AntigensIBA 01/2018
1	copper tetra(4-N-methylpyridyl)porphineIBA 01/2018
1	Anaplastic Lymphoma KinaseIBA 10/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Circulating Tumor DNAIBA 01/2017
1	Interferon-gamma (Interferon, gamma)IBA 01/2016
1	Antitubercular AgentsIBA 05/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2011
1	Anti-Infective Agents (Microbicides)IBA 06/2011
1	Local Anti-Infective Agents (Antiseptics)IBA 06/2011

Therapy/Procedure

4	Therapeutics 10/2022 - 04/2009
1	Catheters 01/2014
1	Artificial Respiration (Mechanical Ventilation) 03/2012